期刊
NATURE MEDICINE
卷 27, 期 8, 页码 1385-+出版社
NATURE PORTFOLIO
DOI: 10.1038/s41591-021-01454-y
关键词
-
资金
- IPA New York
- IPA Washington, DC
- Beyond Conflict
- Bill and Melinda Gates Foundation
- Columbia University
- Givewell.org
- Ghent University
- HSE University Basic Research Program
- International Growth Centre
- Jameel Poverty Action Lab Crime and Violence Initiative
- London School of Economics and Political Science
- Mulago Foundation
- NOVAFRICA at the Nova School of Business and Economics
- NYU Abu Dhabi
- Energy for Economic Growth (EEG) programme - UK Aid
- Princeton University
- Social Science Research Council
- Trinity College Dublin COVID19 Response Funding
- UK Aid
- UKRI GCRF/Newton Fund
- United Nations Office for Project Services
- Weiss Family Fund
- WZB Berlin Social Science Center
- Yale Institute for Global Health
- Yale Macmillan Center
The acceptance of COVID-19 vaccines in LMICs is higher compared to the United States and Russia, with a focus on personal protection and concerns about side effects. Healthcare workers are the most trusted sources of guidance in LMICs for COVID-19 vaccines, suggesting that prioritizing vaccine distribution to these countries could help advance global immunization coverage.
Survey data collected across ten low-income and middle-income countries (LMICs) in Asia, Africa and South America compared with surveys from Russia and the United States reveal heterogeneity in vaccine confidence in LMICs, with healthcare providers being trusted sources of information, as well as greater levels of vaccine acceptance in these countries than in Russia and the United States. Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. Vaccination campaigns should focus on translating the high levels of stated acceptance into actual uptake. Messages highlighting vaccine efficacy and safety, delivered by healthcare workers, could be effective for addressing any remaining hesitancy in the analyzed LMICs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据